NO930693L - Mometasonfuroatmonohydrat, fremgangsmaate for fremstillingav dette og farmasoeytiske preprater - Google Patents

Mometasonfuroatmonohydrat, fremgangsmaate for fremstillingav dette og farmasoeytiske preprater

Info

Publication number
NO930693L
NO930693L NO93930693A NO930693A NO930693L NO 930693 L NO930693 L NO 930693L NO 93930693 A NO93930693 A NO 93930693A NO 930693 A NO930693 A NO 930693A NO 930693 L NO930693 L NO 930693L
Authority
NO
Norway
Prior art keywords
preparation
furoat
mometason
procedure
pharmaceutical preparations
Prior art date
Application number
NO93930693A
Other languages
English (en)
Other versions
NO300548B1 (no
NO930693D0 (no
Inventor
Pui-Ho Yuen
Charles Eckhart
Teresa Etlinger
Nancy Levine
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24320279&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO930693(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO930693L publication Critical patent/NO930693L/no
Publication of NO930693D0 publication Critical patent/NO930693D0/no
Publication of NO300548B1 publication Critical patent/NO300548B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO930693A 1990-09-10 1993-02-26 Fremgangsmåte for fremstilling av mometasonfuroatmonohydrat NO300548B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58023990A 1990-09-10 1990-09-10
PCT/US1991/006249 WO1992004365A1 (en) 1990-09-10 1991-09-06 Mometasone furoate monohydrate, process for making same and pharmaceutical compositions

Publications (3)

Publication Number Publication Date
NO930693L true NO930693L (no) 1993-02-26
NO930693D0 NO930693D0 (no) 1993-02-26
NO300548B1 NO300548B1 (no) 1997-06-16

Family

ID=24320279

Family Applications (1)

Application Number Title Priority Date Filing Date
NO930693A NO300548B1 (no) 1990-09-10 1993-02-26 Fremgangsmåte for fremstilling av mometasonfuroatmonohydrat

Country Status (35)

Country Link
US (1) US6180781B1 (no)
EP (1) EP0548114B1 (no)
JP (1) JPH0725789B2 (no)
KR (1) KR960013445B1 (no)
CN (1) CN1030920C (no)
AT (1) ATE113604T1 (no)
AU (1) AU663471B2 (no)
BG (1) BG60755B2 (no)
CA (1) CA2091360C (no)
CZ (1) CZ281318B6 (no)
DE (2) DE69104991T2 (no)
DK (1) DK0548114T5 (no)
EE (1) EE02962B1 (no)
ES (1) ES2065701T3 (no)
FI (1) FI111078B (no)
HK (1) HK185996A (no)
HR (1) HRP920383B1 (no)
HU (1) HU213401B (no)
IE (1) IE67056B1 (no)
IL (1) IL99437A (no)
LU (1) LU90366I2 (no)
MX (2) MX9203396A (no)
MY (1) MY106644A (no)
NL (1) NL980012I2 (no)
NO (1) NO300548B1 (no)
NZ (1) NZ239711A (no)
OA (1) OA09772A (no)
PH (1) PH30443A (no)
PL (1) PL165803B1 (no)
PT (1) PT98905B (no)
SI (1) SI9111497A (no)
TW (2) TW229208B (no)
WO (1) WO1992004365A1 (no)
YU (1) YU48666B (no)
ZA (1) ZA917148B (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2065701T3 (es) * 1990-09-10 1995-02-16 Schering Corp Furoato de mometasona monohidrato, procedimiento para fabricar el mismo y composiciones farmaceuticas.
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
US5837699A (en) 1994-01-27 1998-11-17 Schering Corporation Use of mometasone furoate for treating upper airway passage diseases
US5886200A (en) * 1996-07-01 1999-03-23 Schering Corporation Process for the preparation of 17-esters of 9 α, 21-dihalo-pregnane-11 β, 17 α-diol-20-ones
US5976573A (en) 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
CN1059476C (zh) * 1996-08-21 2000-12-13 邓维鹏 金黄色铝合金硒盐电解着色方法
US6187765B1 (en) * 1997-10-09 2001-02-13 Schering Corporation Mometasone furoate suspensions for nebulization
JP3676674B2 (ja) * 1997-10-09 2005-07-27 シェーリング コーポレイション 噴霧のためのモメタゾンフロエート懸濁液
MY133181A (en) * 1998-09-10 2007-10-31 Schering Corp Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
PT1175433E (pt) 1999-05-04 2005-11-30 Strakan Int Ltd Glicosidos androgenos e sua actividade androgenica
GB0207906D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
US9808471B2 (en) 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US8912174B2 (en) 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US7811606B2 (en) 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
CA2537185A1 (en) * 2003-08-29 2005-03-10 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
EP1694655A2 (en) * 2003-11-26 2006-08-30 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
US7491725B2 (en) 2004-02-06 2009-02-17 Bristol-Myers Squibb Company Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
EP1934219A1 (en) 2005-09-16 2008-06-25 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
AU2006305620A1 (en) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
US20090221664A1 (en) 2005-10-19 2009-09-03 Abhijit Ray Pharmaceutical compositions of muscarinic receptor antagonists
CN100436473C (zh) * 2005-12-09 2008-11-26 天津药业集团有限公司 糠酸莫美他松中间体21-酯及制法
CN100389121C (zh) * 2005-12-09 2008-05-21 天津药业集团有限公司 糠酸莫美他松中间体21-羟的制备方法
DE102006034883A1 (de) * 2006-07-25 2008-01-31 Hermal Kurt Herrmann Gmbh & Co. Ohg Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat
US20100029728A1 (en) * 2006-09-22 2010-02-04 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
BRPI0717058A2 (pt) * 2006-09-22 2013-10-15 Ranbaxy Lab Ltd Composto, composição farmacêutica, método para tratar, prevenir, inibir ou suprimir uma condição inflamatória ou doença ou doenças do sistema nervoso central e método para a preparação de um composto
EP1958947A1 (en) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type 4
ATE545417T1 (de) 2007-03-14 2012-03-15 Ranbaxy Lab Ltd Pyrazoloä3,4-büpyridin-derivate als phosphodiesterasehemmer
WO2008111009A1 (en) * 2007-03-14 2008-09-18 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
EP3106149B1 (en) 2009-05-29 2019-11-20 Pearl Therapeutics, Inc. Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting beta-2 adrenergic receptor agonists and associated methods and systems
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
PT105058B (pt) 2010-04-21 2013-04-17 Hovione Farmaciencia S A Processo para processamento de partículas de ingredientes activos farmacêuticos
BR112015022784B1 (pt) 2013-03-15 2023-02-14 Pearl Therapeutics, Inc Método de condicionamento de material cristalino micronizado e sistemas de condicionamento
CN107260671B (zh) * 2016-04-08 2021-03-26 天津金耀集团有限公司 一种糠酸莫米松混悬鼻喷剂组合物
CN107266518B (zh) * 2016-04-08 2021-03-30 天津金耀集团有限公司 一种糠酸莫米松晶型及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0057401B1 (en) * 1981-02-02 1984-08-01 Schering Corporation Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
US4783444A (en) 1984-09-17 1988-11-08 Schering Corporation Antiglaucoma compositions and methods
US4808610A (en) * 1986-10-02 1989-02-28 Schering Corporation Mometasone furoate anti-inflammatory cream composition using hexylene glycol
US4775529A (en) * 1987-05-21 1988-10-04 Schering Corporation Steroid lotion
ES2065701T3 (es) * 1990-09-10 1995-02-16 Schering Corp Furoato de mometasona monohidrato, procedimiento para fabricar el mismo y composiciones farmaceuticas.

Also Published As

Publication number Publication date
PT98905B (pt) 1998-08-31
ZA917148B (en) 1992-08-26
HUT64361A (en) 1993-12-28
NL980012I1 (nl) 1998-05-06
ATE113604T1 (de) 1994-11-15
NL980012I2 (nl) 2004-11-01
MX9203396A (es) 1992-07-31
HU9300685D0 (en) 1993-06-28
CZ281318B6 (cs) 1996-08-14
NO300548B1 (no) 1997-06-16
JPH05506667A (ja) 1993-09-30
YU48666B (sh) 1999-06-15
CN1030920C (zh) 1996-02-07
FI111078B (fi) 2003-05-30
WO1992004365A1 (en) 1992-03-19
EE02962B1 (et) 1997-02-17
MX9100990A (es) 1992-05-04
US6180781B1 (en) 2001-01-30
KR960013445B1 (ko) 1996-10-05
SI9111497A (sl) 1998-04-30
CZ38393A3 (en) 1994-01-19
HK185996A (en) 1996-10-11
LU90366I2 (fr) 1999-05-05
BG60755B2 (bg) 1996-02-29
TW229208B (no) 1994-09-01
PH30443A (en) 1997-05-09
YU149791A (sh) 1994-01-20
DK0548114T5 (da) 1995-01-30
MY106644A (en) 1995-07-31
HRP920383B1 (en) 2000-04-30
PT98905A (pt) 1992-09-30
EP0548114B1 (en) 1994-11-02
CN1059911A (zh) 1992-04-01
DE69104991D1 (de) 1994-12-08
CA2091360C (en) 1997-04-08
OA09772A (en) 1993-11-30
IE913155A1 (en) 1992-03-11
DE19875032I2 (de) 2007-04-19
ES2065701T3 (es) 1995-02-16
NZ239711A (en) 1992-09-25
HRP920383A2 (en) 1998-06-30
PL165803B1 (pl) 1995-02-28
NO930693D0 (no) 1993-02-26
IL99437A0 (en) 1992-08-18
IE67056B1 (en) 1996-02-21
HU213401B (en) 1997-06-30
TW272195B (no) 1996-03-11
DE69104991T2 (de) 1995-04-20
AU8497491A (en) 1992-03-30
AU663471B2 (en) 1995-10-12
JPH0725789B2 (ja) 1995-03-22
FI931031L (fi) 1993-03-09
FI931031A0 (fi) 1993-03-09
CA2091360A1 (en) 1992-03-11
IL99437A (en) 1995-05-29
EP0548114A1 (en) 1993-06-30

Similar Documents

Publication Publication Date Title
NO930693L (no) Mometasonfuroatmonohydrat, fremgangsmaate for fremstillingav dette og farmasoeytiske preprater
NO830110L (no) 6-substituert-s-triazolo(3,4-a)ftalazinderivater og fremgangsmaate for deres fremstilling
IL123002A0 (en) 1-Phenyl-2- phenylacetoxy- ethanone derivatives
IL97025A0 (en) 17beta-substituted-4-aza-5alpha-androstan-3-one derivatives,their preparation and pharmaceutical compositions containing them
ES8307794A1 (es) Un procedimiento para la preparacion de agentes antifugicos triazolicos.
DE3163802D1 (en) Cephalosporin derivatives, pharmaceutical compositions and process for their preparation
NZ192195A (en) 1-triazolyl-2-hydroxy-2-phenyl-3-aryl-propanes and pharmaceutical compositions
DK93685A (da) Benzisoselenazolthioner, fremgangsmaade til fremstilling af disse forbindelser og farmaceutiske praeparater indeholdende disse forbindelser
ES8802612A1 (es) Procedimiento para preparar derivados de benzisoselenazolilo
IL66192A (en) Albomycin derivatives,their production and pharmaceutical compositions containing them
ES8206544A1 (es) Procedimiento para la preparacion de 4-carbamoiloxi-oxaza- fosforinas
ES474052A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridazinas 1-n-sustituidas.
ES8506710A1 (es) Procedimiento para la obtencion de teofilin-7-acetato de ambroxol
JO1711B1 (en) Therapeutic agents

Legal Events

Date Code Title Description
MK1K Patent expired